Events  Classes  Deals  Spaces  Jobs 
    Sign in  
With Aubrey de Grey (Chief Science Officer & Co-founder @ SENS Research), Nina Tandon (Co-founder/CEO @ EpiBone and Author of Super Cells: Building with Biology) and Andrew Hessel (Autodesk Bio/Nano Programmable Matter Group).
Thursday, September 04, 2014 at 07:00 PM    Cost: $5
Blueprint Health, 483 Broadway, 2nd fl

Sign up for our awesome New York
Tech Events weekly email newsletter.

Aubrey de Grey, Chief Science Officer and Co-founder of SENS Research Foundation discusses his perspective on living well longer.

"It may seem premature to be discussing the comprehensive medical conquest of human aging when so little progress has yet been made in even postponing it. However, two facts undermine this assessment. The first is that aging happens throughout our lives but only causes ill-health after middle age: this shows that we can postpone that ill-health without knowing how to prevent aging completely, but instead by molecular and cellular repair. The second is that regenerative medicine is now advancing from a futuristic twinkle in a few visionaries' eyes to a realistic strategy for addressing numerous medical conditions. In this talk I will explain why therapies that can add 30 healthy years to the remaining lifespan of typical 60-year-olds may well arrive within the next few decades, with an emphasis on recent progress both in SENS Research Foundation's own work and elsewhere."- de Grey 2014

Bio: Dr. Aubrey de Grey is a biomedical gerontologist based in Cambridge, UK and Mountain View, California, USA, and is the Chief Science Officer of SENS Research Foundation, a California-based 501(c)(3) charity dedicated to combating the aging process. He is also Editor-in-Chief of Rejuvenation Research, the worlds highest-impact peer-reviewed journal focused on intervention in aging. He received his BA and Ph.D. from the University of Cambridge in 1985 and 2000 respectively. His research interests encompass the characterisation of all the accumulating and eventually pathogenic molecular and cellular side-effects of metabolism (damage) that constitute mammalian aging and the design of interventions to repair and/or obviate that damage. Dr. de Grey is a Fellow of both the Gerontological Society of America and the American Aging Association, and sits on the editorial and scientific advisory boards of numerous journals and organisations.

Links: talk:

© 2017 GarysGuide      About   Terms   Press   Feedback